CD44H localization in primary open-angle glaucoma

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 5, 1998, Pages 673-680

  Knepper, Paul A ^a,b   Goossens, William ^a   Mayanil, Chandra S K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AVIDIN; BIOTIN; HERMES ANTIGEN; HYALURONIC ACID; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; TRITON X 100;

ADULT; AGED; ARTICLE; AUTOPSY; CASE REPORT; COMPUTER ANALYSIS; CONTROLLED STUDY; FEMALE; GLAUCOMA; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LASER SURGERY; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; TRABECULOPLASTY;

AGED; ANTERIOR EYE SEGMENT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; BIOLOGICAL MARKERS; CILIARY BODY; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; HYALURONIC ACID; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; IRIS; MALE; MIDDLE AGED; TRABECULAR MESHWORK;

EID: 0031957356     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Entwistle J, Hall CL, Turley EA. HA Receptors: regulators of signalling to the cytoskeleton. J Cell Biochem. 1996;61:569-577.
2. Sherman L, Sleeman J, Dall P, et al. The CD44 proteins in embryonic development and in cancer. Curr Top Microbiol Immunol. 1996;213:249-269.
3. Kaya G, Rodriguez I, Jorcano JL, Vassalli P, Stamenkovic I. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev. 1997;11:996-1007.
4. Nishina S, Hirakata A, Hida T, Sawa H, Azuma N. CD44 expression in the developing human retina. Graefes Arch Clin Exp Ophthalmol. 1997;235:92-96.
5. Chaitin MH, Wortham HS, Brun-Zinkernagel AM. Immunocytochemical localization of CD44 in mouse retina. Exp Eye Res. 1994;58:359-365.
6. Cohen MB, Griebling TL, Ahaghotu CA, Rokhlin OW, Ross JS. Cellular adhesion molecules in urologie malignancies. Am J Clin Pathol. 1997;107:56-63.
7. Svee K, White J, Vaillant P, et al. Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44. J Clin Invest. 1996;98:1713-1727.
8. Naot D, Sionov RV, Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res. 1997;71: 241-319.
9. Culty M, Nguyen HA, Underhill CB. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol. 1992;116:1055-1062.
10. Rafi A, Nagarkatti M, Nagarkatti PS. Hyaluronate-CD44 interactions can induce murine B-cell activation. Blood. 1997;89:2901-2908.
11. Aruffo A. CD44: one ligand, two functions. J Clin Invest. 1996;98: 2191-2192.
12. Pericle F, Sconocchia G, Titus JA, Segal DM. CD-44 is a cytotoxic triggering molecule on human polymorphonuclear cells. J Immunol. 1996;157:4657-4663.
13. Naujokas MF, Morin M, Anderson MS, Peterson M, Miller J. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses though interaction with CD44. Cell. 1993; 74:257-268.
14. Quigley, HA. Open-angle glaucoma. N Engl J Med. 1993;328:1097-1106.
15. Grierson I, Swalem A, Davies H, Hogg P, Batterbury M, Watson P. Pathological dilemmas in the outflow system in primary open-angle glaucoma. Acta Ophthalmol Scand Suppl. 1997;220:7-14.
16. Quigley HA, Vitale S. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci. 1997;38:83-91.
17. Stone EM, Fingert JH, Alward WLM, et al. Identification of the gene causing juvenile onset primary open angle glaucoma. Science. 1997;275:668-670.
18. Wirtz MK, Samples JR, Kramer PL, et al. Mapping a gene for adult-onset primary open-angle glaucoma to chromosome 3q. Am J Hum Genet. 1997;60:296-304.
19. Alvarado J, Murphy C, Polansky J, Juster R. Age-related changes in trabecular meshwork cellularity. Invest Ophthalmol Vis Sci. 1981; 21:714-727.
20. Quigley HA. Ganglion cell death in glaucoma: pathology recapitulates ontogeny. Aust N Z J Ophthalmol. 1995;23:85-91.
21. Samples JR, Alexander JP, Acott, TS. Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone. Invest Ophthalmol Vis Sci. 1993; 34:3386-3395.
22. Knepper PA, Goossens W, Palmberg PF. Glycosaminoglycan profile of the human trabecular meshwork in primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 1996;37:1360-1367.
23. Knepper PA, Goossens W, Palmberg PF. Glycosaminoglycan stratification in normal and primary open-angle glaucoma juxtacanalicular tissue. Invest Ophthalmol Vis Sci. 1996;37:2414-2425.
24. Parshley DE, Bradley JM, Fisk A, et al. Laser trabeculoplasty induces stromelysin expression by trabecular juxtacanalicular cells. Invest Ophthalmol Vis Sci. 1996;37:795-804.
25. Parshley DE, Bradley JM, Samples JR, Van Buskirk EM, Acott TS. Early changes in matrix metalloproteinases and inhibitors after in vitro laser treatment to the trabecular meshwork. Curr Eye Res. 1995;14:537-544.
26. Knepper PA, Lukas R, Wills J, Goossens W, Mayanil CSK. Hyaluronic acid receptors of the human trabecular meshwork [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1997;38:S451. Abstract nr 2119.
27. Helenius A, Simons K. Solubilization of membranes by detergents. Biochim Biophys Acta. 1975;415:29-79.
28. Neame SJ, Uff CR, Sheikh H, Wheatley SC, Isacke CM. CD44 exhibits a cell type dependent interaction with triton X-100 insoluble, lipid rich, plasma membrane domains. J Cell Sci. 1995;108:3127-3135.
29. Perschl A, Lesley J, English N, Hyman R, Trowbridge IS. Transmembrane domain of CD44 is required for its detergent insolubility in fibroblasts. J Cell Sci. 1995;108:1033-1041.
30. Youngentob SL, Kent PF, Sheehe PR, Schwob JE, Tzoumaka E. Mucosal inherent activity patterns in the rat: evidence from voltage-sensitive dyes. J Neurophysiol. 1995;73:387-398.
31. Chodosh J, Dix RD, Howell RC, Stroop WG, Tseng SC. Staining characteristics and antiviral activity of sulfohodamine B and lissamine green B. Invest Ophthalmol Vis Sci. 1994;35:1046-1058.
32. Pennell NA, Hurley SD, Streit WJ. Lcctin staining of sheep microglia. Histochemistry. 1994;102:483-486.
33. Tsukita A, Oishi K, Sato N, Sagara J, Kawai A, Tsukita S. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol. 1994;126: 391-401.
34. Jassim A, Chen YL. AJ-FS1 monoclonal antibody detects a novel group of non-glycosylated antigens within the human sperm tail fibrous sheath. Hum Reprod. 1994;9:1459-1465.
35. Hogan MJ, Alvarado, JA, Weddell JE. Histology of the Human Eye. Philadelphia, PA: Saunders; 1971:297-311.
36. Ehrke MJ, Verstovsek S, Krawczyk CM, et al. Cyclophosphamide plus tumor necrosis factor-alpha chemoimmunotherapy cured mice: life-long immunity and rejection of re-implanted primary lymphoma. Int J Cancer. 1995;63:463-471.
37. Barrat F, Haegel H, Louise A, et al. Quantitative and qualitative changes in CD44 and MEL-14 expression by T cells in C57BL/6 mice during aging. Res Immunol. 1995;146:23-34.
38. Brissett NC, Perkins SJ. The protein fold of the hyaluronate-binding proteoglycan tandem repeat domain of link protein, aggrecan and CD44 is similar to that of the C-type lectin superfamily. FEBS Lett. 1996;388:211-216.
39. Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle, N. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol. 1995;128:673-685.
40. Screaton GR, Bell MV, Bell JI, Jackson, DG. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the pgp-1(CD44) homing receptor. Comparison of all 10 variable exons between mouse, human and rat. J Biol Chem. 1993;268:12235-12238.
41. Harn HJ, Ho LI, Yu CP, et al. The variant mRNA isoform of human metastasis gene (CD44) detected in cell lines of human hepatocellular carcinoma. Biochem Mol Biol Int. 1994;32:233-238.
42. Fujita N, Yaegashi N, Ide Y, et al. Expression of CD44 in normal versus tumor endometrial tissues: possible implications of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Cancer Res. 1994;54:3922-3928.
43. Fox SB, Fawcett J, Jackson DG, et al. Normal human tissues, in addition to some tumors, express multiple different isoforms. Cancer Res. 1994;54:4539-4546.
44. Lesley J, He Q, Miyake K, Hamann A, Hyman R, Kincade PW. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J Exp Med. 1992; 175:257-266.
45. Underhill C. CD44: the hyaluronan receptor. J Cell Sci. 1992;103: 293-298.
46. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with the extracellular matrix. Adv Immunol. 1993;54:271-335.
47. Adolph VR, Bleacher JC, Dillon PW, Krummel TM. Hyaluronate uptake and CD44 activity in fetal and adult fibroblasts. J Surg Res. 1993;54:328-330.
48. Lokeshwar VB, Fregien N, Bourguignon LY. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acidmediated adhesion function. J Cell Biol. 1994;126:1099-1109.
49. Camp RL, Krauss TA, Pure E. Variations in the cytoskeletal interaction and posttranslational modifications of the CD44 homing receptor in macrophages. J Cell Biol. 1991;115:1283-1292.
50. Sretavan DW, Feng L, Pure E, Reichardt LF. Embryonic neurons of the developing optic chiasm express L1 and CD44, cell surface molecules with opposing effects on retinal axon growth. Neuron. 1994;12:957-975.
51. Girgrah N, Letarte M, Becker LE, Cruz TF, Theriault E, Miscarello MA. Localization of the CD44 glycoprotein to fibrous astrocytes in normal white matter and to reactive astrocytes in active lesions in multiple sclerosis. J Neuropathol Exp Neurol. 1991;50:779-792.
52. Sprent J, Tough DF. Lymphocyte life-span and memory. Science. 1994;265:1395-1400.
53. Galandrini R, De Maria R, Piccoli M, Frati L, Santoni A. CD44 triggering enhances human NK cell cytotoxic functions. J Immunol. 1994;153:4399-4407.
54. Sconocchia G, Titus JA, Segal DM. CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells. J Immunol. 1994; 153:5473-5481.
55. Tan PH, Santos EB, Rossbach HC, Sandmaier BM. Enhancement of natural killer activity by an antibody to CD44. J Immunol. 1993; 150:812-820.
56. Yang H, Binns RM. CD44 is involved in porcine natural cytotoxicity. Cell Immunol. 1993;149:227-237.
57. Tan PH, Liu Y, Santos EB, Sandmaier, BM. Mechanisms of enhancement of natural killer activity by an antibody to CD44: increase in conjugate formation and release of tumor necrosis factor alpha. Cell Immunol. 1995;164:255-264.
58. Acott TS, Samples JR, Bradley JM, Bacon DR, Bylsma SS, Van Buskirk EM. Trabecular repopulation by anterior trabecular meshwork cells after laser trabeculoplasty. Am J Ophthamol. 1989;107: 1-6.